#ESHMM2027
REGISTRATION AND ABSTRACT SUBMISSION ARE OPEN!
Chairpersons: Hermann Einsele, Martin Kaiser, Omar Nadeem, Sonja Zweegman

MULTIPLE MYELOMA – How translational research transformed and
guides clinical practice and vice versa – For both scientists and clinicians
February 25-27, 2027
Vienna, Austria
Chairpersons: Hermann Einsele, Martin Kaiser, Omar Nadeem, Sonja Zweegman
#ESHMM2027
About the conference:
ESH is pleased to announce the launch of a new meeting dedicated to Multiple Myeloma, bringing together both clinical and translational perspectives, while actively involving young clinicians and scientists in the programme. This meeting combines basic science, translational science and clinical decision, making debates on hot topics in MM / SMM. They will include clinical case presentations and discussions, as well as keynote lectures on novel treatment approaches.
Main Scientific Topics:
• The non-smouldering developments in smouldering myeloma
• To treat or not to treat SMM
• The reality of CAR-T and BsAb therapy - sequencing matters!
• What to do first in first-line therapy - controversies
• CAR-T cells or Bispecifics?
• Moving earlier to T-cell therapies in early relapse
• How to treat in later lines when T-cell have become exhausted treating
• Gain greater insight through a deep and broad perspective: the role of deep sequencing and spatial transcriptomics
• Will we still do transplants in 2030
• Treatment endpoints in multiple myeloma
• Hot topics

